Jenburkt Pharmaceuticals Ltd.
Snapshot View

500.00 +16.20 ▲3.4%

27 June 2022, 04:01:00 PM
Volume: 403

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jenburkt.com
Market Cap 233.42 Cr.
Enterprise Value(EV) 186.26 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 48.58 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 10.47 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 255.77 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.99 Calculated using Price: 508.60
Dividend Yield 2.01 Period Ending 2021-03
No. of Shares Subscribed 0.46 Cr. 4,589,378 Shares
FaceValue 10
Company Profile
Jenburkt Pharmaceuticals Ltd, a venture to diversify into the healthcare and pharmaceutical industry, was formed in 1985 by the Bhuta family; late Hemendra N. Bhuta was the promoter of the company while the Bhuta Group was founded by Nandlal Mulji Bhuta

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+3.35%
1 Week
+7.04%
1 Month
-8.11%
3 Month
-6.68%
6 Month
-7.58%
1 Year
+2.46%
2 Year
+30.58%
5 Year
-2.16%
10 Year
+615.82%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 30.06 30.05 31.77 29.28 28.55 29.75 28.54 18.89 18.49
Return on Capital Employed (%) 40.35 40.94 42.35 40.17 39.26 41.99 36.90 25.73 23.83
Return on Assets (%) 13.92 16.15 18.40 18.13 20.10 22.36 21.99 14.37 14.68

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 23 27 33 40 54 61 77 80 98 117
Non Curr. Liab. 9 4 3 4 4 3 0 5 4 4
Curr. Liab. 18 13 24 14 18 13 25 20 18 21
Minority Int.
Equity & Liab. 49 44 61 58 76 78 103 104 120 143
Non Curr. Assets 15 14 12 13 13 12 13 15 40 67
Curr. Assets 34 30 49 45 64 66 90 90 80 76
Misc. Exp. not W/O
Total Assets 49 44 61 58 76 78 103 104 120 143

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 69 76 85 94 103 115 123 119 109 124
Other Income 1 2 2 3 3 3 3 4 4 5
Total Income 70 78 87 96 106 118 126 123 114 129
Total Expenditure -59 -65 -70 -77 -84 -91 -98 -99 -89 -97
PBIDT 11 13 17 19 23 27 28 24 24 32
Interest -1 -1 0 0 0 0 0 -1 0 0
Depreciation -1 -2 -3 -2 -2 -2 -1 -2 -2 -2
Taxation -3 -3 -5 -6 -7 -8 -7 -6 -5 -8
Exceptional Items 0 0 0 0
PAT 6 8 10 11 14 17 20 15 17 22
Adjusted EPS 13 16 21 23 29 38 43 32 36 49

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 7 5 11 9 8 10 16 13 15 19
Cash Fr. Inv. -3 -1 0 1 0 -10 1 -11 -3 -19
Cash Fr. Finan. -2 0 -7 1 -5 1 -18 -2 -11 -1
Net Change 2 3 5 11 2 1 -1 0 1 0
Cash & Cash Eqvt 8 11 17 28 30 2 1 1 3 2

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 45.73 45.73 45.73 45.73 45.73 45.73 45.73 45.73 45.73
Public 54.27 54.27 54.27 54.27 54.27 54.27 54.27 54.27 54.27
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 24 Jun 2022
Closure of Trading Window
Closure of Trading Window under "Jenburkt Pharmaceuticals Limiteds code on prohibition of Insider Trading" from 01.07.2022 till 48 hours after the price sensitive information viz. UFR pertaining to the quarter ended on 30.06.2022 are disseminated or made public.
Wed, 08 Jun 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding loss of share certificate of Mr.Yogesh Gavankar and issuance of Letter of Confirmation (duplicate share certificate) in lieu thereof.
Sat, 04 Jun 2022
Statement Of Related Party Transactions For The Half Year Ended 31St March 2022.
Statement of Related Party Transactions for the half year ended 31st March 2022

Technical Scans View Details

Mon, 27 Jun 2022
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Month High Decrease 1 Month

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. 48,438.53 2,858.25 -0.6%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.24 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.12 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,858.25 -0.6%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%

FAQ's On Jenburkt Pharmaceuticals Ltd.

Can I Buy Jenburkt Pharma Shares now?

What is the Share Price of Jenburkt Pharma?

What is the Relative Strength Index (RSI) Value of Jenburkt Pharma?

What is the Market Capital (MCAP) of Jenburkt Pharma?

What are the key metrics to analyse Jenburkt Pharma?

What is the Price Performance of Jenburkt Pharma?